UK clarifies post-BREXIT batch testing rules for pharmaceuticals
The UK government has announced its future strategy for batch testing of medicinal products. The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations. Post-BREXIT, the pharmaceutical industry urged the UK… Read More